165 related articles for article (PubMed ID: 30678233)
1. Tribbles Homolog 3 Involved in Radiation Response of Triple Negative Breast Cancer Cells by Regulating Notch1 Activation.
Lee YC; Wang WL; Chang WC; Huang YH; Hong GC; Wang HL; Chou YH; Tseng HC; Lee HT; Li ST; Chen HL; Wu CC; Yang HF; Wang BY; Chang WW
Cancers (Basel); 2019 Jan; 11(2):. PubMed ID: 30678233
[TBL] [Abstract][Full Text] [Related]
2. TRIB3 confers radiotherapy resistance in esophageal squamous cell carcinoma by stabilizing TAZ.
Zhou S; Liu S; Lin C; Li Y; Ye L; Wu X; Jian Y; Dai Y; Ouyang Y; Zhao L; Liu M; Song L; Xi M
Oncogene; 2020 Apr; 39(18):3710-3725. PubMed ID: 32157210
[TBL] [Abstract][Full Text] [Related]
3. Tribbles Pseudokinase 3 Contributes to Cancer Stemness of Endometrial Cancer Cells by Regulating β-Catenin Expression.
Wang WL; Hong GC; Chien PJ; Huang YH; Lee HT; Wang PH; Lee YC; Chang WW
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33334065
[TBL] [Abstract][Full Text] [Related]
4. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
5. Metabolic and lipidomic characterization of radioresistant MDA-MB-231 human breast cancer cells to investigate potential therapeutic targets.
Lee H; To NB; Kim M; Nguyen YT; Cho SK; Choi HK
J Pharm Biomed Anal; 2022 Jan; 208():114449. PubMed ID: 34749107
[TBL] [Abstract][Full Text] [Related]
6. c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun.
Xie X; Kaoud TS; Edupuganti R; Zhang T; Kogawa T; Zhao Y; Chauhan GB; Giannoukos DN; Qi Y; Tripathy D; Wang J; Gray NS; Dalby KN; Bartholomeusz C; Ueno NT
Oncogene; 2017 May; 36(18):2599-2608. PubMed ID: 27941886
[TBL] [Abstract][Full Text] [Related]
7. Additive Pharmacological Interaction between Cisplatin (CDDP) and Histone Deacetylase Inhibitors (HDIs) in MDA-MB-231 Triple Negative Breast Cancer (TNBC) Cells with Altered Notch1 Activity-An Isobolographic Analysis.
Wawruszak A; Luszczki JJ; Kalafut J; Okla K; Halasa M; Rivero-Muller A; Stepulak A
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357442
[TBL] [Abstract][Full Text] [Related]
8. HIF-2α regulates CD44 to promote cancer stem cell activation in triple-negative breast cancer
Bai J; Chen WB; Zhang XY; Kang XN; Jin LJ; Zhang H; Wang ZY
World J Stem Cells; 2020 Jan; 12(1):87-99. PubMed ID: 32110277
[TBL] [Abstract][Full Text] [Related]
9. TRIB3 protein denotes a good prognosis in breast cancer patients and is associated with hypoxia sensitivity.
Wennemers M; Bussink J; Grebenchtchikov N; Sweep FC; Span PN
Radiother Oncol; 2011 Oct; 101(1):198-202. PubMed ID: 21704407
[TBL] [Abstract][Full Text] [Related]
10. Building radiation-resistant model in triple-negative breast cancer to screen radioresistance-related molecular markers.
Zhou ZR; Wang XY; Yu XL; Mei X; Chen XX; Hu QC; Yang ZZ; Guo XM
Ann Transl Med; 2020 Feb; 8(4):108. PubMed ID: 32175401
[TBL] [Abstract][Full Text] [Related]
11. Major vault protein is a direct target of Notch1 signaling and contributes to chemoresistance in triple-negative breast cancer cells.
Xiao YS; Zeng D; Liang YK; Wu Y; Li MF; Qi YZ; Wei XL; Huang WH; Chen M; Zhang GJ
Cancer Lett; 2019 Jan; 440-441():156-167. PubMed ID: 30336197
[TBL] [Abstract][Full Text] [Related]
12. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
[TBL] [Abstract][Full Text] [Related]
13. Niclosamide sensitizes triple-negative breast cancer cells to ionizing radiation in association with the inhibition of Wnt/β-catenin signaling.
Yin L; Gao Y; Zhang X; Wang J; Ding D; Zhang Y; Zhang J; Chen H
Oncotarget; 2016 Jul; 7(27):42126-42138. PubMed ID: 27363012
[TBL] [Abstract][Full Text] [Related]
14. Baicalein Suppresses Stem Cell-Like Characteristics in Radio- and Chemoresistant MDA-MB-231 Human Breast Cancer Cells through Up-Regulation of IFIT2.
Koh SY; Moon JY; Unno T; Cho SK
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30875792
[TBL] [Abstract][Full Text] [Related]
15. Nonstructural 3 Protein of Hepatitis C Virus Modulates the Tribbles Homolog 3/Akt Signaling Pathway for Persistent Viral Infection.
Tran SC; Pham TM; Nguyen LN; Park EM; Lim YS; Hwang SB
J Virol; 2016 Aug; 90(16):7231-7247. PubMed ID: 27252525
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of TMPRSS4 Enhances Triple-Negative Breast Cancer Cell Radiosensitivity Through Cell Cycle and Cell Apoptosis Process Impairment.
Assani G; Segbo J; Yu X; Yessoufou A; Xiong Y; Zhou F; Zhou Y
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3679-3687. PubMed ID: 31870109
[TBL] [Abstract][Full Text] [Related]
17. CPNE1 predicts poor prognosis and promotes tumorigenesis and radioresistance via the AKT singling pathway in triple-negative breast cancer.
Shao Z; Ma X; Zhang Y; Sun Y; Lv W; He K; Xia R; Wang P; Gao X
Mol Carcinog; 2020 May; 59(5):533-544. PubMed ID: 32181526
[TBL] [Abstract][Full Text] [Related]
18. The Pseudokinase TRIB3 Negatively Regulates the HER2 Receptor Pathway and Is a Biomarker of Good Prognosis in Luminal Breast Cancer.
Orea-Soufi A; Castillo-Lluva S; Salvador-Tormo N; Martín-Cabrera P; Recuero S; Gabicagogeascoa E; Moreno-Valladares M; Mendiburu-Eliçabe M; Blanco-Gómez A; Ramos-Pittol JM; García-Taboada E; Ocaña A; Cimas FJ; Matheu A; Álvarez-López I; Velasco G; Lorente M
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771470
[TBL] [Abstract][Full Text] [Related]
19. Schlafen12 Reduces the Aggressiveness of Triple Negative Breast Cancer through Post-Transcriptional Regulation of ZEB1 That Drives Stem Cell Differentiation.
Al-Marsoummi S; Vomhof-DeKrey E; Basson MD
Cell Physiol Biochem; 2019; 53(6):999-1014. PubMed ID: 31838790
[TBL] [Abstract][Full Text] [Related]
20. ADAM10 is involved in the oncogenic process and chemo-resistance of triple-negative breast cancer via regulating Notch1 signaling pathway, CD44 and PrPc.
Cheng Y; Lin L; Li X; Lu A; Hou C; Wu Q; Hu X; Zhou Z; Chen Z; Tang F
Cancer Cell Int; 2021 Jan; 21(1):32. PubMed ID: 33413403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
